Company Spotlight

Biosynth Carbosynth

4 Rietlistrasse,
Staad, SG 9422
Switzerland
View Profile

Almac Group

Almac House, 20 Seagoe Industrial Estate
Armagh, BT63 5QD
United Kingdom
View Profile

Quotient Sciences

3080 McCann Farm Drive
Garnet Valley, PA 19060
United States
View Profile


Contract Service Directory


Biochempeg Scientific





Company Headquarters


108 Water Street, Room 4D
沃特敦, MA United States

Contract Service Directory

    Related Content

    • Breaking News | Collaborations & Alliances | Industry News
      Asychem Partners with LaNova Medicines

      Asychem Partners with LaNova Medicines

      Will provide one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.
      09.16.21

    • Breaking News | Collaborations & Alliances | Industry News
      Innovent Biologics Signs License Agreement with Synaffix

      Innovent Biologics Signs License Agreement with Synaffix

      Synaffix will provide proprietary ADC technologies to enable Innovent to rapidly progress one of its antibodies as a best-in-class ADC candidate.
      07.01.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
      WuXi XDC and LegoChem Ink ADC Agreement

      WuXi XDC and LegoChem Ink ADC Agreement

      Sign MOU for the development and manufacturing of antibody-drug conjugates.
      06.11.21


    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Inspections | Process Validation | Risk Management
      Establishing Commercial Manufacturing Services for Antibody-Drug Conjugates

      Establishing Commercial Manufacturing Services for Antibody-Drug Conjugates

      Learn how to properly structure your development work, perform a thorough process risk assessment and prepare for pre-approval inspection audit.

    • HPAPI Development and Manufacturing Trends

      HPAPI Development and Manufacturing Trends

      The current trend of increased potency of drug substances is driving the need for better cleaning methods to reduce cross contamination.
      05.20.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      WuXi Biologics, WuXi STA Establish WuXi XDC JV

      WuXi Biologics, WuXi STA Establish WuXi XDC JV

      To provide contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs).
      Kristin Brooks 05.14.21


    • Breaking News | Facilities | Industry News
      Lonza to Build Small Molecule Manufacturing Complex in Visp

      Lonza to Build Small Molecule Manufacturing Complex in Visp

      Will invest $220 million to construct the complex that will include a manufacturing line for antibody-drug conjugate payload molecules.
      Tim Wright, Editor, Contract Pharma 04.23.21

    • Cytotoxics and High Potency Manufacturing | Facilities | Solid Dosage/Creams/Ointments
      Outsourcing Solid Dosage Manufacturing

      Outsourcing Solid Dosage Manufacturing

      A Q&A with Dan Dobry, head of drug product commercial development at Lonza Pharma & Biotech.
      Tim Wright, Editor, Contract Pharma 03.12.21

    • Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
      Lonza Expands Conjugation Facility in Visp

      Lonza Expands Conjugation Facility in Visp

      Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.
      Contract Pharma Staff 12.21.20


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact

      Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact

      Will advance a new generation of antibody-drug conjugates towards clinical evaluation.
      Contract Pharma Staff 12.03.20

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Lonza Enters Long-term Bioconjugation Collaboration

      Lonza Enters Long-term Bioconjugation Collaboration

      Will construct two new customer-dedicated conjugation suites for the commercialization of antibody-drug conjugates at its Visp site.
      Contract Pharma Staff 12.02.20

    • Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
      Lonza Opens Facility for ADC Payload Manufacturing

      Lonza Opens Facility for ADC Payload Manufacturing

      Expansion is based on agreement with a major biopharma partner that ensures ADC payload supply continuity and flexibility.
      Contract Pharma Staff 11.05.20


    • Breaking News | Collaborations & Alliances | Industry News
      Avacta Enters Collaboration with ADC Therapeutics

      Avacta Enters Collaboration with ADC Therapeutics

      Focus on developing potent Affimer-drug conjugates.
      10.10.19